Osamu Arasaki
Tomigusuku, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Atypical Presentation of Microscopic Polyangiitis with Pericarditis Manifesting as Right-Sided Heart Failure.
Journal: Internal medicine (Tokyo, Japan)
Published: July 12, 2026
Body mass index and sarcopenia and mortality risk among older hypertensive outpatients; the Nambu Cohort Study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: June 27, 2024
Sex differences in the association between epicardial adipose tissue volume and left atrial volume index.
Journal: BMC cardiovascular disorders
Published: July 10, 2023
Serial Electrocardiographic Changes in Early Post-myocardial Infarction Pericarditis.
Journal: Cureus
Published: July 12, 2022
Effect of Anagliptin versus Sitagliptin on Renal Function: Subanalyzes from the REASON Trial.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: November 21, 2021
Blood pressure, frailty status, and all-cause mortality in elderly hypertensives; The Nambu Cohort Study.
Journal: Hypertension research : official journal of the Japanese Society of Hypertension
Published: July 21, 2021
The association between frailty and chronic kidney disease; cross-sectional analysis of the Nambu Cohort Study.
Journal: Clinical and experimental nephrology
Published: June 18, 2021
Prognostic Impact of Early Changes in Serum Chloride Concentrations Among Hospitalized Acute Heart Failure Patients - A Retrospective Cohort Study.
Journal: Circulation reports
Published: March 11, 2021
Differential Effects of DPP-4 Inhibitors, Anagliptin and Sitagliptin, on PCSK9 Levels in Patients with Type 2 Diabetes Mellitus who are Receiving Statin Therapy.
Journal: Journal of atherosclerosis and thrombosis
Published: December 21, 2020
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial.
Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial.
Journal: Diabetes, metabolic syndrome and obesity : targets and therapy
Published: September 20, 2020
Independent and Distinct Associations of FABP4 and FABP5 With Metabolic Parameters in Type 2 Diabetes Mellitus.
Journal: Frontiers in endocrinology
Published: June 23, 2020
Last Updated: 09/26/2026